# Xellar Biosystems raises RMB 200 million in Series A financing

On 2026-04-02, according to Xiniu Data, Xellar Biosystems completed Series A financing, raising RMB 200 million. Investors were lead investor Guoshouguquan, participating investor Jingtai Holdings, participating investor Yayi Capital, participating investor Junlian Capital. The company is an AI drug discovery platform.



Canonical: https://uniquebase.ai/news/cc10d6c4-c494-498c-a42b-51626a59d58c
Stable identifier: cc10d6c4-c494-498c-a42b-51626a59d58c
Snapshot captured: 2026-10-20T18:19:32.670Z
English updated: 2026-10-20T18:23:00.769Z

## Connected profiles

- [Guoshouguquan](/institutions/guoshouguquan)
- [Jingtai Technology](/institutions/jingtai-technology)
- [Junlian Capital](/institutions/junlian-capital)
- [Xellar Biosystems](/companies/xellar-biosystems)
- [Yayi Capital](/institutions/yayi-capital)

## Sources

- No source links are available for this profile.